Study protocol: a randomized, double-blind, parallel, two-arm, placebo control trial investigating the feasibility and safety of immunoglobulin treatment in COPD patients for prevention of frequent recurrent exacerbations

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a chronic progressive inflammatory disease of the airways, associated with frailty, disability, co-morbidity, and mortality. Individuals with COPD experience increased risk and rates of acute exacerbation as their lung disease worsens. Curr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cowan, Juthaporn, Mulpuru, Sunita, Aaron, Shawn, Alvarez, Gonzalo, Giulivi, Antonio, Corrales-Medina, Vicente, Thiruganasambandamoorthy, Venkatesh, Thavorn, Kednapa, Mallick, Ranjeeta, Cameron, D. William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087014/
https://www.ncbi.nlm.nih.gov/pubmed/30116551
http://dx.doi.org/10.1186/s40814-018-0327-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087014/
https://www.ncbi.nlm.nih.gov/pubmed/30116551
http://dx.doi.org/10.1186/s40814-018-0327-z

Ejemplares similares